Clinical diagnosis of IC/BPS was based on standardized East Asian protocols and ESSIC diagnostic criteria, including chronic bladder-related pain lasting more than 6 months with at least one additional lower urinary tract symptom 48,49
BPC-157 accelerates healing through different mechanisms, promoting angiogenesis and growth factor production
PlexusDx recommends genetic testing and baseline labs before attempting dual therapy, along with conservative dosing and frequent follow-up
Several observational studies using similar formulations and instillation protocols ranging from weekly to monthly to PRN and follow-up intervals of a few months to several years reported efficacy rates of 25 to 90%
But cost and insurance questions often get in the way
Additionally, AOD-9604 is not FDA-approved for weight loss, and its legality varies depending on the country